Xia Li

机构：Henan University, Beijing University of Chinese Medicine, Fudan University, West China Medical Center of Sichuan University, Lishui University, Lishui Central Hospital, Precision for Medicine (United States), AstraZeneca (United States), First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0001-7252-6907

发表论文 72 篇 · 总被引 1041 次 · h-index 19

代表论文

• Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming (2023 · Cell Death and Disease · 被引 35)
• Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study (2024 · BMC Cancer · 被引 19)
• Chemical composition, pharmacological activity and development strategies of Rubus chingii: A review (2024 · Chinese Herbal Medicines · 被引 15)
• Icaritin greatly attenuates β‐amyloid‐induced toxicity in vivo (2023 · CNS Neuroscience & Therapeutics · 被引 10)
• Redox homeostasis of one-carbon metabolism-dependent reprogramming is critical for RCC progression under exogenous serine/glycine-deprived conditions (2024 · BMC Cancer · 被引 8)
• Glutathione S‐Transferase Contributes to the Resistance of Megalurothrips usitatus Against Lambda‐Cyhalothrin by Strengthening Its Antioxidant Defense Mechanisms (2024 · Archives of Insect Biochemistry and Physiology · 被引 8)